(Japanese)

(Japanese)

(Japanese)

Dramatically

Accelerating 

Infectious Disease Research.

Our MPV* and Mylc** cells, produced with regenerative medicine technologies, will solve the shortage of experimental cells for researches on malaria and other infectious diseases, and help researchers accelerate their experiments exponentially.

* We are now providing test

and pilot products and will

start full-scale production in 2020.

** We start to sell this product from 12th Dec in 2019. 

NEWS RELEASE

June 16 ,2020

We'll present the functional analysis of myeloid linage cell (Mylc cell) at poster session III in ISSCR 2020.

April 20 ,2020

We are attending COVID-19 Virtual Partnering event to find collaborators to develop solutions

April 14 ,2020

Our activities was introduced on the site of the discover the deep tech startups fighting COVID-19 

PRODUCT  Video

PRODUCT  LINE-UP

Mpv

immature

red blood-like cells for

Malaria (P.vivax)

research

Mylc

special

myeloid lineage cells for

Dengue and other infectious diseases

© 2019 MiCAN Technologies Inc.

KKVP, 1-36 Goryo-ohara, Nishikyo-ku, Kyoto 615-8245 Japan

​〒615-8245 京都市西京区御陵大原1-36 京大桂ベンチャープラザ